Novel Function of lncRNA ADAMTS9-AS2 in Promoting Temozolomide Resistance in Glioblastoma via Upregulating the FUS/MDM2 Ubiquitination Axis

Frontiers in Cell and Developmental Biology - Switzerland
doi 10.3389/fcell.2019.00217
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

DNA-methylation-mediated Activating of lncRNA SNHG12 Promotes Temozolomide Resistance in Glioblastoma

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2020English

Metabolic Targeting of EGFRvIII/PDK1 Axis in Temozolomide Resistant Glioblastoma

Oncotarget
Oncology
2017English

A Novel Enhancer Regulates MGMT Expression and Promotes Temozolomide Resistance in Glioblastoma

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2018English

Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma

Neurologia Medico-Chirurgica
SurgeryNeurology
2018English

Augmented HR Repair Mediates Acquired Temozolomide Resistance in Glioblastoma

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2016English

Upregulated lncRNA ADAMTS9-AS2 Suppresses Progression of Lung Cancer Through Inhibition of miR-223-3p and Promotion of TGFBR3

IUBMB Life
BiochemistryGeneticsClinical BiochemistryCell BiologyMolecular Biology
2018English

JNK Contributes to Temozolomide Resistance of Stem-Like Glioblastoma Cells via Regulation of MGMT Expression

International Journal of Oncology
Cancer ResearchOncology
2013English

LncRNA NEAT1 Enhances the Radio-Resistance of Cervical Cancer via miR-193b-3p/CCND1 Axis

Oncotarget
Oncology
2017English

Intracellular Redox-Balance Involvement in Temozolomide Resistance-Related Molecular Mechanisms in Glioblastoma

Cells
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy